India Plans Immediate Permit Halts for Not of Standard Quality Medications
The central government has proposed an immediate suspension of manufacturing permits for medicines classified as Not of Standard Quality. This regulatory step aims to tighten quality controls across pharmaceutical supply chains to protect public health. Industry participants must review compliance measures carefully as authorities finalize these rules.
Effective Not specified in the update
For professionals: Licensed pharmaceutical manufacturers must audit their internal quality assurance protocols immediately · Compliance officers should review raw material testing records and assess batch failure risks right away
Open for the full story →